does semaglutide affect kidney function in patients with overweight or obesity and chronic disease without diabetes: a randomized double-blind placebo-controlled clinical trial Kidney and Survival Outcomes with

Eli Lilly is awaiting an FDA decision for a new indication for Mounjaro to reduce the risk of a major adverse cardiovascular event (MACE) in patients with type 2 diabetes mellitus (T2DM)

The additional glucagon receptor activity is hypothesised to further enhance energy expenditure and fat oxidation

They craft a personalized treatment plan considering your health goals, pertinent lab work, and any existing health barriers, setting you on a path to success

Many clients at our medical spa have experienced a radiant glow and improved complexion after undergoing Glutathione Detox

At 68 weeks, CagriSema produced a mean body weight reduction of 22.7% from baseline